Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Harvard Business School

Last Updated: December 7, 2022

Details for Patent: 8,569,325

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 8,569,325
Title:Method of treatment with coadministration of aspirin and prasugrel
Abstract: A method for the prevention of diseases caused by thrombus or embolus. The method is to separately administer 2-acetoxy-5-(.alpha.-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahyd- rothieno[3,2-c]pyridine or a pharmaceutically acceptable salt thereof, and aspirin, in their pharmacologically effective amounts, to a warm-blooded animal.
Inventor(s): Asai; Fumitoshi (Nishitokyo, JP), Sugidachi; Atsuhiro (Kawasaki, JP), Ogawa; Taketoshi (Tokyo, JP), Inoue; Teruhiko (Ube, JP)
Assignee: Daiichi Sankyo Company, Limited (Tokyo, JP) Ube Industries, Ltd. (Yamaguchi, JP)
Application Number:12/006,546
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,569,325
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 8,569,325

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,569,325

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2000-392983Dec 25, 2000

International Family Members for US Patent 8,569,325

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 407675 See Plans and Pricing
Australia 2002217464 See Plans and Pricing
Brazil 0116531 See Plans and Pricing
Canada 2432644 See Plans and Pricing
China 100341506 See Plans and Pricing
China 1491109 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.